Effects of melatonin in perimenopausal and menopausal women: a randomized and placebo controlled study
In aging humans, night levels of melatonin (MEL) decline progressively. Also thyroid and gonadal functions decline during aging while gonadotropins (luteotropic hormone (LH) and follicle stimulating hormone (FSH)) steadily increase. A desynchronization of pineal circadian cyclicity as expressed by t...
Gespeichert in:
Veröffentlicht in: | Experimental gerontology 2001-02, Vol.36 (2), p.297-310 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 310 |
---|---|
container_issue | 2 |
container_start_page | 297 |
container_title | Experimental gerontology |
container_volume | 36 |
creator | Bellipanni, G Bianchi, P Pierpaoli, W Bulian, D Ilyia, E |
description | In aging humans, night levels of melatonin (MEL) decline progressively. Also thyroid and gonadal functions decline during aging while gonadotropins (luteotropic hormone (LH) and follicle stimulating hormone (FSH)) steadily increase. A desynchronization of pineal circadian cyclicity as expressed by the progressive decrease of the MEL night peak may be permissively linked to the onset and progression of menopause. We studied the effects of exogenous, evening administration of MEL on the level of hormones which are known to be involved in the genesis and progression of menopause.
Perimenopausal and menopausal women from 42 to 62
years of age with no pathology or medication were selected. MEL was measured in saliva to divide them into low, medium and high-MEL patients. Half of them took 3
mg MEL and half of them Placebo at bedtime (10–12
p.m.) in a fully randomized and double-blind fashion. Three and six months later blood was taken for determination of pituitary (LH, FSH), ovarian, and thyroid hormones I(T
3 and T
4). All women taking MEL with low basal level of MEL and/or Placebo for three and six months showed a significant increase in levels of thyroid hormones. Before initiation of the study, a negative correlation was found in all women between LH, FSH and basal MEL levels. Within six months of treatment, MEL produced a significant diminution of LH in the younger women (43 to 49
year-old), while no effect was seen in the older women (50–62
years old). A decrement of FSH was observed in MEL-treated women with low basal MEL levels. In addition, most MEL-treated women reported a general improvement of mood and a significant mitigation of depression. MEL decline during aging may thus signal the derangement of pineal and pituitary-controlled ovarian cyclicity and the progressive quenching of fertility in women. These findings seem to show a recovery of pituitary and thyroid functions in MEL-treated women, towards a more juvenile pattern of regulation. |
doi_str_mv | 10.1016/S0531-5565(00)00217-5 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70651782</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0531556500002175</els_id><sourcerecordid>70651782</sourcerecordid><originalsourceid>FETCH-LOGICAL-c438t-97222ba86e0d26a18a763b247f1e50dfe82ebda59f8cdbe54702c092b75178723</originalsourceid><addsrcrecordid>eNqFkE1r3DAQQEVJaDbb_oQGn0J7cDKSLcnbSyjL5gMWckh7FrI0AhfbciW7YfPrK-8uaW6BgWGkNzPMI-QLhSsKVFw_AS9ozrngXwG-ATAqc_6BLGgli1xUlJ-QxStyRs5j_A0AghX0IzmjlDEhy3JB3MY5NGPMvMs6bPXo-6bPUgwYmg57P-gp6jbTvc3elM8-Fd8znYX04bvmBe0eGVptsPaZ8f0YfNum5zhOdveJnDrdRvx8zEvy63bzc32fbx_vHtY_trkpi2rMV5IxVutKIFgmNK20FEXNSukocrAOK4a11XzlKmNr5KUEZmDFasmprCQrluTyMHcI_s-EcVRdEw22re7RT1FJEDM5g_wAmuBjDOjUkO7VYacoqFmw2gtWsz0FoPaCFU99F8cFU92h_d91NJqAmwOA6cy_DQYVTYO9QduEJFpZ37yz4h-gjoul</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70651782</pqid></control><display><type>article</type><title>Effects of melatonin in perimenopausal and menopausal women: a randomized and placebo controlled study</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Bellipanni, G ; Bianchi, P ; Pierpaoli, W ; Bulian, D ; Ilyia, E</creator><creatorcontrib>Bellipanni, G ; Bianchi, P ; Pierpaoli, W ; Bulian, D ; Ilyia, E</creatorcontrib><description>In aging humans, night levels of melatonin (MEL) decline progressively. Also thyroid and gonadal functions decline during aging while gonadotropins (luteotropic hormone (LH) and follicle stimulating hormone (FSH)) steadily increase. A desynchronization of pineal circadian cyclicity as expressed by the progressive decrease of the MEL night peak may be permissively linked to the onset and progression of menopause. We studied the effects of exogenous, evening administration of MEL on the level of hormones which are known to be involved in the genesis and progression of menopause.
Perimenopausal and menopausal women from 42 to 62
years of age with no pathology or medication were selected. MEL was measured in saliva to divide them into low, medium and high-MEL patients. Half of them took 3
mg MEL and half of them Placebo at bedtime (10–12
p.m.) in a fully randomized and double-blind fashion. Three and six months later blood was taken for determination of pituitary (LH, FSH), ovarian, and thyroid hormones I(T
3 and T
4). All women taking MEL with low basal level of MEL and/or Placebo for three and six months showed a significant increase in levels of thyroid hormones. Before initiation of the study, a negative correlation was found in all women between LH, FSH and basal MEL levels. Within six months of treatment, MEL produced a significant diminution of LH in the younger women (43 to 49
year-old), while no effect was seen in the older women (50–62
years old). A decrement of FSH was observed in MEL-treated women with low basal MEL levels. In addition, most MEL-treated women reported a general improvement of mood and a significant mitigation of depression. MEL decline during aging may thus signal the derangement of pineal and pituitary-controlled ovarian cyclicity and the progressive quenching of fertility in women. These findings seem to show a recovery of pituitary and thyroid functions in MEL-treated women, towards a more juvenile pattern of regulation.</description><identifier>ISSN: 0531-5565</identifier><identifier>EISSN: 1873-6815</identifier><identifier>DOI: 10.1016/S0531-5565(00)00217-5</identifier><identifier>PMID: 11226744</identifier><language>eng</language><publisher>England: Elsevier Inc</publisher><subject>Adult ; Affect - drug effects ; Circadian Rhythm - drug effects ; Circadian Rhythm - physiology ; Depression ; Depression - drug therapy ; Double-Blind Method ; Female ; Follicle Stimulating Hormone - blood ; Gonadal Steroid Hormones - blood ; Gonadotropins ; Humans ; Luteinizing Hormone - blood ; Melatonin ; Melatonin - administration & dosage ; Melatonin - pharmacology ; Melatonin - physiology ; Menopause - drug effects ; Menopause - physiology ; Menopause - psychology ; Menstrual Cycle - drug effects ; Middle Aged ; Perimenopause ; Pineal gland ; Premenopause - drug effects ; Premenopause - physiology ; Premenopause - psychology ; Thyroid function ; Thyrotropin - blood ; Thyroxine - blood ; Triiodothyronine - blood</subject><ispartof>Experimental gerontology, 2001-02, Vol.36 (2), p.297-310</ispartof><rights>2001 Elsevier Science Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c438t-97222ba86e0d26a18a763b247f1e50dfe82ebda59f8cdbe54702c092b75178723</citedby><cites>FETCH-LOGICAL-c438t-97222ba86e0d26a18a763b247f1e50dfe82ebda59f8cdbe54702c092b75178723</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0531556500002175$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11226744$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bellipanni, G</creatorcontrib><creatorcontrib>Bianchi, P</creatorcontrib><creatorcontrib>Pierpaoli, W</creatorcontrib><creatorcontrib>Bulian, D</creatorcontrib><creatorcontrib>Ilyia, E</creatorcontrib><title>Effects of melatonin in perimenopausal and menopausal women: a randomized and placebo controlled study</title><title>Experimental gerontology</title><addtitle>Exp Gerontol</addtitle><description>In aging humans, night levels of melatonin (MEL) decline progressively. Also thyroid and gonadal functions decline during aging while gonadotropins (luteotropic hormone (LH) and follicle stimulating hormone (FSH)) steadily increase. A desynchronization of pineal circadian cyclicity as expressed by the progressive decrease of the MEL night peak may be permissively linked to the onset and progression of menopause. We studied the effects of exogenous, evening administration of MEL on the level of hormones which are known to be involved in the genesis and progression of menopause.
Perimenopausal and menopausal women from 42 to 62
years of age with no pathology or medication were selected. MEL was measured in saliva to divide them into low, medium and high-MEL patients. Half of them took 3
mg MEL and half of them Placebo at bedtime (10–12
p.m.) in a fully randomized and double-blind fashion. Three and six months later blood was taken for determination of pituitary (LH, FSH), ovarian, and thyroid hormones I(T
3 and T
4). All women taking MEL with low basal level of MEL and/or Placebo for three and six months showed a significant increase in levels of thyroid hormones. Before initiation of the study, a negative correlation was found in all women between LH, FSH and basal MEL levels. Within six months of treatment, MEL produced a significant diminution of LH in the younger women (43 to 49
year-old), while no effect was seen in the older women (50–62
years old). A decrement of FSH was observed in MEL-treated women with low basal MEL levels. In addition, most MEL-treated women reported a general improvement of mood and a significant mitigation of depression. MEL decline during aging may thus signal the derangement of pineal and pituitary-controlled ovarian cyclicity and the progressive quenching of fertility in women. These findings seem to show a recovery of pituitary and thyroid functions in MEL-treated women, towards a more juvenile pattern of regulation.</description><subject>Adult</subject><subject>Affect - drug effects</subject><subject>Circadian Rhythm - drug effects</subject><subject>Circadian Rhythm - physiology</subject><subject>Depression</subject><subject>Depression - drug therapy</subject><subject>Double-Blind Method</subject><subject>Female</subject><subject>Follicle Stimulating Hormone - blood</subject><subject>Gonadal Steroid Hormones - blood</subject><subject>Gonadotropins</subject><subject>Humans</subject><subject>Luteinizing Hormone - blood</subject><subject>Melatonin</subject><subject>Melatonin - administration & dosage</subject><subject>Melatonin - pharmacology</subject><subject>Melatonin - physiology</subject><subject>Menopause - drug effects</subject><subject>Menopause - physiology</subject><subject>Menopause - psychology</subject><subject>Menstrual Cycle - drug effects</subject><subject>Middle Aged</subject><subject>Perimenopause</subject><subject>Pineal gland</subject><subject>Premenopause - drug effects</subject><subject>Premenopause - physiology</subject><subject>Premenopause - psychology</subject><subject>Thyroid function</subject><subject>Thyrotropin - blood</subject><subject>Thyroxine - blood</subject><subject>Triiodothyronine - blood</subject><issn>0531-5565</issn><issn>1873-6815</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1r3DAQQEVJaDbb_oQGn0J7cDKSLcnbSyjL5gMWckh7FrI0AhfbciW7YfPrK-8uaW6BgWGkNzPMI-QLhSsKVFw_AS9ozrngXwG-ATAqc_6BLGgli1xUlJ-QxStyRs5j_A0AghX0IzmjlDEhy3JB3MY5NGPMvMs6bPXo-6bPUgwYmg57P-gp6jbTvc3elM8-Fd8znYX04bvmBe0eGVptsPaZ8f0YfNum5zhOdveJnDrdRvx8zEvy63bzc32fbx_vHtY_trkpi2rMV5IxVutKIFgmNK20FEXNSukocrAOK4a11XzlKmNr5KUEZmDFasmprCQrluTyMHcI_s-EcVRdEw22re7RT1FJEDM5g_wAmuBjDOjUkO7VYacoqFmw2gtWsz0FoPaCFU99F8cFU92h_d91NJqAmwOA6cy_DQYVTYO9QduEJFpZ37yz4h-gjoul</recordid><startdate>20010201</startdate><enddate>20010201</enddate><creator>Bellipanni, G</creator><creator>Bianchi, P</creator><creator>Pierpaoli, W</creator><creator>Bulian, D</creator><creator>Ilyia, E</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20010201</creationdate><title>Effects of melatonin in perimenopausal and menopausal women: a randomized and placebo controlled study</title><author>Bellipanni, G ; Bianchi, P ; Pierpaoli, W ; Bulian, D ; Ilyia, E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c438t-97222ba86e0d26a18a763b247f1e50dfe82ebda59f8cdbe54702c092b75178723</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Adult</topic><topic>Affect - drug effects</topic><topic>Circadian Rhythm - drug effects</topic><topic>Circadian Rhythm - physiology</topic><topic>Depression</topic><topic>Depression - drug therapy</topic><topic>Double-Blind Method</topic><topic>Female</topic><topic>Follicle Stimulating Hormone - blood</topic><topic>Gonadal Steroid Hormones - blood</topic><topic>Gonadotropins</topic><topic>Humans</topic><topic>Luteinizing Hormone - blood</topic><topic>Melatonin</topic><topic>Melatonin - administration & dosage</topic><topic>Melatonin - pharmacology</topic><topic>Melatonin - physiology</topic><topic>Menopause - drug effects</topic><topic>Menopause - physiology</topic><topic>Menopause - psychology</topic><topic>Menstrual Cycle - drug effects</topic><topic>Middle Aged</topic><topic>Perimenopause</topic><topic>Pineal gland</topic><topic>Premenopause - drug effects</topic><topic>Premenopause - physiology</topic><topic>Premenopause - psychology</topic><topic>Thyroid function</topic><topic>Thyrotropin - blood</topic><topic>Thyroxine - blood</topic><topic>Triiodothyronine - blood</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bellipanni, G</creatorcontrib><creatorcontrib>Bianchi, P</creatorcontrib><creatorcontrib>Pierpaoli, W</creatorcontrib><creatorcontrib>Bulian, D</creatorcontrib><creatorcontrib>Ilyia, E</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Experimental gerontology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bellipanni, G</au><au>Bianchi, P</au><au>Pierpaoli, W</au><au>Bulian, D</au><au>Ilyia, E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of melatonin in perimenopausal and menopausal women: a randomized and placebo controlled study</atitle><jtitle>Experimental gerontology</jtitle><addtitle>Exp Gerontol</addtitle><date>2001-02-01</date><risdate>2001</risdate><volume>36</volume><issue>2</issue><spage>297</spage><epage>310</epage><pages>297-310</pages><issn>0531-5565</issn><eissn>1873-6815</eissn><abstract>In aging humans, night levels of melatonin (MEL) decline progressively. Also thyroid and gonadal functions decline during aging while gonadotropins (luteotropic hormone (LH) and follicle stimulating hormone (FSH)) steadily increase. A desynchronization of pineal circadian cyclicity as expressed by the progressive decrease of the MEL night peak may be permissively linked to the onset and progression of menopause. We studied the effects of exogenous, evening administration of MEL on the level of hormones which are known to be involved in the genesis and progression of menopause.
Perimenopausal and menopausal women from 42 to 62
years of age with no pathology or medication were selected. MEL was measured in saliva to divide them into low, medium and high-MEL patients. Half of them took 3
mg MEL and half of them Placebo at bedtime (10–12
p.m.) in a fully randomized and double-blind fashion. Three and six months later blood was taken for determination of pituitary (LH, FSH), ovarian, and thyroid hormones I(T
3 and T
4). All women taking MEL with low basal level of MEL and/or Placebo for three and six months showed a significant increase in levels of thyroid hormones. Before initiation of the study, a negative correlation was found in all women between LH, FSH and basal MEL levels. Within six months of treatment, MEL produced a significant diminution of LH in the younger women (43 to 49
year-old), while no effect was seen in the older women (50–62
years old). A decrement of FSH was observed in MEL-treated women with low basal MEL levels. In addition, most MEL-treated women reported a general improvement of mood and a significant mitigation of depression. MEL decline during aging may thus signal the derangement of pineal and pituitary-controlled ovarian cyclicity and the progressive quenching of fertility in women. These findings seem to show a recovery of pituitary and thyroid functions in MEL-treated women, towards a more juvenile pattern of regulation.</abstract><cop>England</cop><pub>Elsevier Inc</pub><pmid>11226744</pmid><doi>10.1016/S0531-5565(00)00217-5</doi><tpages>14</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0531-5565 |
ispartof | Experimental gerontology, 2001-02, Vol.36 (2), p.297-310 |
issn | 0531-5565 1873-6815 |
language | eng |
recordid | cdi_proquest_miscellaneous_70651782 |
source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
subjects | Adult Affect - drug effects Circadian Rhythm - drug effects Circadian Rhythm - physiology Depression Depression - drug therapy Double-Blind Method Female Follicle Stimulating Hormone - blood Gonadal Steroid Hormones - blood Gonadotropins Humans Luteinizing Hormone - blood Melatonin Melatonin - administration & dosage Melatonin - pharmacology Melatonin - physiology Menopause - drug effects Menopause - physiology Menopause - psychology Menstrual Cycle - drug effects Middle Aged Perimenopause Pineal gland Premenopause - drug effects Premenopause - physiology Premenopause - psychology Thyroid function Thyrotropin - blood Thyroxine - blood Triiodothyronine - blood |
title | Effects of melatonin in perimenopausal and menopausal women: a randomized and placebo controlled study |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T17%3A09%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20melatonin%20in%20perimenopausal%20and%20menopausal%20women:%20a%20randomized%20and%20placebo%20controlled%20study&rft.jtitle=Experimental%20gerontology&rft.au=Bellipanni,%20G&rft.date=2001-02-01&rft.volume=36&rft.issue=2&rft.spage=297&rft.epage=310&rft.pages=297-310&rft.issn=0531-5565&rft.eissn=1873-6815&rft_id=info:doi/10.1016/S0531-5565(00)00217-5&rft_dat=%3Cproquest_cross%3E70651782%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70651782&rft_id=info:pmid/11226744&rft_els_id=S0531556500002175&rfr_iscdi=true |